Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 12Lung Neoplasms 9Colorectal Neoplasms 8Prostatic Neoplasms 7Pancreatic Neoplasms 3Ovarian Neoplasms 3Colonic Neoplasms 3Skin Carcinoma 2Melanoma 2Malignant Solid Neoplasm 2Lymphoma 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Spondylitis, Ankylosing 1Sleep Wake Disorders 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostate 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Pain 1Overweight 1Obesity-Related Malignant Neoplasm 1Obesity 1

Interventions

cabozantinib 5Nivolumab 4Ipilimumab 4Axitinib 4pembrolizumab 3Blood Specimen Collection 3zimberelimab 2atezolizumab 2Surveys and Questionnaires 2Sunitinib 2Irinotecan 2temsirolimus 1spartalizumab 1salicylhydroxamic acid 1palbociclib 1orellanine 1olaparib 1liposomal doxorubicin 1lenvatinib 1gallium Ga 68 dotatate 1fludarabine 1brodalumab 1belzutifan 1aldesleukin 1adagrasib 1Vincristine 1Temozolomide 1Taxes 1Selenomethionine 1Ropivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Early Intervention, Educational × 90 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡